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Abstract
Background: All flour in the USA is fortified with folic acid at a level of 140 µg/100 g which is
estimated to supply an extra 100 µg daily to the average diet. Some researchers have advocated
that this be increased to double and even four times this amount. Based on previous research these
higher levels are likely to lead to the appearance of unmetabolised vitamin in the circulation, which
may have safety implications for sub-groups of the population. The UK and the Republic of Ireland
will likely introduce mandatory fortification also in the next year or so.
The aim of this study was to capture the short-term effect of folic acid fortification on
unmetabolised folic acid in serum after chronic consumption of folic acid.
Methods: After pre-saturation with 400 µg folic acid supplements daily for 14-weeks, healthy
folate replete adults (n = 20) consumed folic acid fortified bread, at three different levels (400 µg,
200 µg, 100 µg) over a period of one week each. The dose was administered in two-equal sized
slices consumed at 09.00 hrs and 13.00 hrs. Serum samples for total folate and folic acid were
collected at baseline, after 14-weeks of supplementation, and pre and post (at 1, 2, 3 and 4 hours)
each dose tested.
Results: Unmetabolised folic acid was detected after the 14-week supplementation period. Folic
acid was not detected in either the 200 µg or 100 µg (current US regime) doses tested but was
present at the highest level (400 µg) tested.
Conclusion:  Our findings suggest that persons exposed to the current US fortification
programme supplying an average of 100 µg per day or less are unlikely to have unmetabolised folic
acid in serum. It also seems that daily consumption of the higher level of 200 µg or less is unlikely
to be problematic. Increasing the level however to 400 µg on the other hand is likely to lead to
unmetabolised folic acid appearance.
Background
To prevent Neural Tube Defects (NTDs) the Food and
Drug Administration (FDA), USA implemented manda-
tory folic acid fortification of flour. This commenced in
January 1998. The fortification level was set at 140 µg/100
g flour supplying ~100 µg daily to the average American.
This amount was selected on the basis that it would not
result in intakes in excess of 1 mg (upper safe daily limit)
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by any population group. Doubt has been cast on the
actual level of fortification however and recent calcula-
tions have shown that the level of folic acid fortification is
likely to have been over twice the amount mandated [1]
with average intakes ranging from 215 to 240 µg/day.
The Centers for Disease Control (CDC) supported the for-
tification strategy but because this level fell short of the
target to supply 400 µg to all women of childbearing age,
they considered increasing the level to 350 µg and even
700 µg/100 g, which would supply approximately 2.5 and
5 times more folic acid respectively [2] The primary con-
cern with these higher levels of fortification is that certain
segments of the population will be exposed to amounts of
folic acid greater than 1000 µg/day and that this may have
adverse effects.
After much deliberation by the relevant authorities in the
UK folic acid will be added to bread in the UK within a
year. In addition the Republic of Ireland have opted for
mandatory fortification, which will be fully implemented
in the next year.
Research to date suggests that the enzymatic reduction
and methylation of folic acid during its absorption in the
intestine or its first pass through the liver is dose-depend-
ent. Hence oral folic acid above certain threshold doses
saturates the normal intestinal absorptive mechanisms
and results in unmetabolised folic acid in serum as well as
the normal metabolite 5-methyltetrahydrofolate. This has
been demonstrated at oral doses in the region of 200 µg
[3] and 266 µg [4]. In a more recent paper it was shown
that repeated consumption of physiological amounts of
folic acid lead to the accumulation of unmetabolised folic
acid in serum [5]. It has also been demonstrated that pas-
sive consumption of folic acid in foodstuffs by pregnant
women leads to the appearance of unmetabolised folic
acid in foetal cord blood [6]. While these studies exam-
ined the acute serum response to folic acid, none have
investigated the effect after a prolonged period of expo-
sure to the vitamin.
Folic acid has the potential to mask the early haematolog-
ical manifestations of pernicious anaemia. This has been
demonstrated experimentally [7-10] and clinically [11-
15]. Other safety considerations of excess folic acid con-
sumption highlighted by the FDA [16] include potential
unknown risks for pregnant women, and persons on anti-
epileptic and anti-folate medication. The FDA also noted
the uncertainties regarding the effects of chronic exposure
in children, whose requirements for folate are lower than
those of adults. Furthermore evidenced based [17,18] and
hypothetical concerns include the potential to promote
cancer [19,20] and the recent hypothesis that exposure of
the foetus to excess folic acid may favour the selection of
the Methylentetrahydrofolate polymorphism, associated
with a range of debilitating illnesses [21].
To date no studies have examined the effect of long-term
consumption of folic acid on unmetabolised folic acid in
serum. The accumulation of folic acid after consumption
of fortified bread repeatedly over only one 8-hour period
[5] provides justification for this. In this paper we exam-
ined unmetabolised folic acid appearance after consump-
tion of folic acid for a prolonged period. The three levels
selected to be tested were in the region of that already
implemented in the mandatory US fortification pro-
gramme and the two higher levels considered by the CDC.
Methods
Fortification of bread
3 batches of bread were made specifically for the study by
Superquinn Bakeries Kimmage, Dublin, under the super-
vision of the principal researcher. Batch 1 supplied 50 µg
per slice, batch 2 supplied 100 µg per slice and batch 3
supplied 200 µg per slice. Each slice weighed about 30 g.
The folic acid was added to water, which was then mixed
with the flour and other dry ingredients. The dough was
formed by thorough mixing with an industrial mixer. The
bread was then baked under normal conditions and
stored in a food freezer at -20°C until eaten (approxi-
mately 2–6 weeks in total). Preliminary research by the
researcher showed that folic acid does not degrade under
these conditions [22].
Participants
20 healthy adult subjects, 10 females and 10 males, aged
20–40 years of age were recruited by voluntary participa-
tion from the student and staff population of the Central
Pathology laboratory, St. James's Hospital, Dublin and
from the general population. Ethical approval was
obtained from the Ethics Committee of the Federated
Dublin Voluntary Hospital, James's Street, Dublin. After
informed consent from all participants a medical history
was taken and all subjects were found to be free of vascu-
lar, hepatic, renal or gastrointestinal disease. Oral contra-
ceptive pill users were excluded from participating, as
were those taking multi-vitamin preparations or anti-con-
vulsant therapy. One subject dropped out of the study for
personal reasons. 19 subjects completed the study.
Intervention-phase I
For clarity a flow diagram illustrating diagrammatically
the interventions and sampling points is included (figure
1). After confirming that all subjects were folate replete at
recruitment by performing red cell and serum folate meas-
urements (table 1) subjects were instructed to consume
one 400 µg folic acid supplement daily for 14 weeks. The
rationale for this regime was to saturate the subjects at the
highest level of fortification to be tested in the study. FromBMC Public Health 2007, 7:41 http://www.biomedcentral.com/1471-2458/7/41
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previous research [23] we knew it takes 14-weeks to reach
a serum folate plateau at this dose. Baseline serum unme-
tabolised folic acid concentrations were also established
(table 1). Subjects were issued with folic acid supplements
(Clonfolic 400 µg) and were instructed to omit all other
sources of folic acid either in supplemental from or in for-
tified foods for the duration of the study. A list of com-
mercially available folic acid fortified foodstuffs as well as
single/multivitamin preparations containing folic acid on
the Irish market was issued to each subject. A list of suita-
ble non-fortified substitutes was issued and subjects were
reimbursed financially for these products in order to
improve compliance. Subjects were contacted weekly
either by telephone or in person throughout the duration
of the study to enhance and improve motivation.
Serum samples were collected for red cell, serum folate
and unmetabolised folic acid at week 10 and week 14
post-supplementation. At both of these time-points sam-
ples were collected 6-hours after the vitamin had last been
consumed to allow time for the acute post-prandial folic
acid to clear from the circulation.
Intervention-phase II
Week 1
After the 14-week supplementation period bread was
administered to subjects (Regime C) supplying a total of
400 µg of folic acid in 2 slices over a period of 7 days. The
1st slice was consumed each day at breakfast time (09.00
hrs) and the 2nd slice was consumed 4 hours later at lunch-
time (13.00 hrs).
Week 2
Bread was administered to subjects (Regime B) supplying
a total of 200 µg of folic acid in 2 slices over a period of 7
days. The 1st slice was consumed each day at breakfast
time (09.00 hrs) and the 2nd slice was consumed 4 hours
later at lunchtime (13.00 hrs).
Week 3
Bread was administered to subjects (Regime A) supplying
a total of 100 µg of folic acid in 2 slices over a period of 7
days. The 1st slice was consumed each day at breakfast
time (09.00 hrs) and the 2nd slice was consumed 4 hours
later at lunchtime (13.00 hrs).
Between weeks 1, 2 and 3 subjects consumed a 400 µg
supplement daily for 7-days in an attempt to re-saturate
total serum folate levels.
Blood collection
On day 7 of each bread regime (A, B and C) the subjects
were asked to come to the laboratory at 8 am having fasted
from the folic acid fortified bread since the previous
lunchtime. Hence approximately 20 hours had lapsed
since their last intake of folic acid. An intravenous cannula
was inserted and a pre-prandial serum sample (i) was col-
lected for unmetabolised folic acid and serum folate from
each subject. This sample was collected in order to estab-
lish a pre-prandial baseline before each of the bread regi-
mens. The first slice of bread was then administered.
Serum samples were collected every hour for 4 hours
(samples ii, iii, iv and v). The second slice of bread was
This flow diagram illustrates diagrammatically the interventions and sampling points Figure 1
This flow diagram illustrates diagrammatically the interventions and sampling points. Schematic summary of inter-
vention phases and sample collection. * = Folate and Folic Acid blood sample. RCF = Red cell folate blood sample. § = Day 7, 
trial of bread regimes (200 µg, 100 µg, 50 µg).
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then administered and serum samples were collected
every hour for 3 hours (samples vi, vii and viii). It was
thought that this pattern would give a good overall picture
of the appearance (if present) of unmetabolised folic acid
and of the duration of its presence.
Laboratory analysis
All samples were assayed for total serum folate and red
cell folates by the L. casei microbiological assay described
by [24]. Analysis of samples for unmetabolised folic acid
was carried out by HPLC separation of the folic acid fol-
lowed by solid phase extraction [4]. The re-suspended
folic acid was quantified by the L. casei microbiological
assay above. The lower limit of detection of the assay was
calculated to be 0.3125 ng/ml.
Statistical Analysis
Statistical analysis was performed using the computer
package Data Desk 5.0. Repeated measures anova was
used when comparing serum folic acid/total folate con-
centrations at one time point with serum folic acid/total
folate concentrations at another time point. Post Hoc
Scheffe tests were employed to compare serum folic acid/
total folate concentrations at multiple sampling points.
Results
Intervention phase 1
Baseline red cell and serum folate concentrations were
within normal reference ranges for all subjects (Table 1).
Unmetabolised folic acid was not detected in any of the
baseline samples collected at week 0 (Table 1). Serum
folate concentrations increased significantly from week 0
to week 14 after the supplementation regime (p < 0.001))
as did red cell folate concentrations (p < 0.001) (table 2).
At week 14, 6-hours after consumption of the 400 µg sup-
plement unmetabolised folic acid was present in the sera
of 18 subjects (n = 19). 7 of these 18 subjects demon-
strated only slightly elevated folic acid levels, which were
calculated to be below the level of that which is accurately
quantifiable. Nonetheless the difference between week 0
and week 14 was statistically significant (p < 0.001) dem-
onstrating that the supplementation did give rise to an
elevated folic acid level, which was still detectable six
hours after it had been consumed (Table 2).
Intervention- phase II
Unmetabolised folic acid was present in the sera of 17
subjects (n = 19) on day 7 of regime C bread pre-prandi-
ally (sample i). All of these were above the lowest limit of
quantification and were statistically different from week
14 levels (p < 0.001) (see figure 2). Unmetabolised folic
acid levels increased post-prandially in all subjects after
consumption of the first slice of bread containing 200 µg
folic acid (p < 0.001) (figure 2). It was also present in the
sera of all subjects after the 2nd slice containing a further
200 µg (p < 0.001) (figure 2).
Post hoc analysis showed that differences in serum folic
acid were significant between samples i and samples ii (p
< 0.001), samples i and samples iii (p < 0.001), samples i
and samples vi (p < 0.001) and samples i and samples vii
(p < 0.001). An accumulative elevation of unmetabolised
folic acid was demonstrated in 12 out of 19 subjects after
the 2nd slice (see figure 2). Unmetabolised folic acid was
not detected in the sera of any of the subjects on day 7 of
regime B or A bread pre- or post-prandially (tables 3 and
4).
Table 2: Mean red cell folate (µg/L), total serum folate (µg/L) and unmetabolised folic acid (µg/L) concentrations at week-14 (n = 19).
Subjects Serum folate Red cell folate Folic acid
Mean 14.77 693.94 0.21
SD 5.01 198.72 0.16
CI (95%) 12.38 – 19.22 434.87 – 903.49 0.29 – 0.52
This table illustrates mean red cell folate (µg/L), total serum folate and unmetabolised folic acid (µg/L) concentrations after consuming a 400 µg folic 
acid supplement daily for 14 weeks (n = 19). 6 subjects had detectable folic acid levels (>0.312 µg/L).
Normal reference range for red cell folate is in the range of 150–1000 µg/L and for total serum folate is 2.7–20 µg/L
Table 1: Mean red cell (µg/L) and serum folate (µg/L) concentrations at recruitment (n = 19).
Serum folate Red cell folate Folic acid
Mean 7.60 477.97 0.00
SD 4.25 173.99 -------
CI (95%) 5.55 – 9.65 364.10 – 531.83 -------
This table illustrates mean baseline red cell (µg/L) and total serum folate concentrations (µg/L) at recruitment (n = 19). No subjects had detectable 
serum folic acid at baseline (>0.312 µg/L).
Normal reference range for red cell folate is in the range of 150–1000 µg/L and for total serum folate is 2.7–20 µg/LBMC Public Health 2007, 7:41 http://www.biomedcentral.com/1471-2458/7/41
Page 5 of 7
(page number not for citation purposes)
Table 3: Serum folate and serum folic acid (µg/l). Samples collected on day 7 of regime B bread (100 µg in each slice) pre and post 
prandially.
pre 1st slice 1 hour post 2 hrs post 3 hrs post 4 hrs post 1 hour post 2nd slice 2 hrs post 3 hrs post
Serum folate i ii iii iv v vi vii viii
Mean 14.1111 14.70 15.16 14.72 14.41 14.43 13.84 13.28
SD 5.24 5.59 4.99 5.32 5.83 5.78 5.25 5.47
CI (95%) 11.59 – 16.63 12.00 – 17.39 12.75 – 17.56 12.16 – 17.28 11.60 – 17.22 11.65 – 17.22 11.23 – 16.45 10.46 – 16.10
This table illustrates mean total serum folate (µg/L) concentrations in a group of healthy adult subject (n = 19) exposed to a folic fortified bread for 
1-week. Subject were pre-saturated with folic acid supplements for 14-weeks prior to the bread. The bread was fortified with 100 µg folic acid per 
slice, which was administered twice a day for seven days. The samples shown here were collected on the 7th day of bread consumption pre-
prandially and post-prandially. Standard deviations and confidence intervals are also shown. Serum folic acid was not detectable at any sampling 
points
Mean total serum folate (µg/L) and mean serum unmetabolised folic acid (µg/L) pre and post regime C bread (n = 19) Figure 2
Mean total serum folate (µg/L) and mean serum unmetabolised folic acid (µg/L) pre and post regime C bread 
(n = 19). This graph illustrates mean total serum folate (µg/L) and mean serum unmetabolised folic acid (µg/L) concentrations 
in a group of healthy adult subject (n = 19) exposed to a folic fortified bread for 1-week. Subject were pre-saturated with folic 
acid supplements for 14-weeks prior to the bread. The bread was fortified with 200 µg folic acid per slice, which was adminis-
tered twice a day for seven days. The samples shown here were collected on the 7th day of bread consumption pre-prandially 
and post-prandially.BMC Public Health 2007, 7:41 http://www.biomedcentral.com/1471-2458/7/41
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Total folate concentrations did not change significantly
over the 8 hours after regime C (P = 0.8941), regime B (P
= 0.9820) or regime A bread (p = 0.8829) (figure 2).
Discussion
Unmetabolised folic acid was not detected in any of the
subjects at week 0. It was detected in the serum of all sub-
jects after consumption of a 400 µg folic acid supplement
daily for 14 weeks even though the samples were collected
six-hours after the last supplement. It is likely then that
women complying with the current DOH (UK) [25] rec-
ommendation to consume a 400 µg supplement daily for
their entire childbearing years would be exposed to unme-
tabolised folic acid in serum for at least six out of twenty-
four hours every day. The safety implications of this are
unknown but long-term surveillance of serum folic acid at
a population level may be useful to observe if an accumu-
lation occurs over time.
Out of the three fortified bread regimens administered
only the highest one (400 µg administered in two equal
doses) lead to the appearance of folic acid in serum. Both
the first and the second slice lead to this effect and an
accumulation was noted after the second one. Whether
these levels would accumulate indefinitely or plateau at
some point with prolonged repeated exposure in a popu-
lation exposed to these levels under a fortification pro-
gramme is unknown but again ongoing surveillance is
indicated.
From a positive viewpoint our data shows that unmetab-
olised folic acid did not appear in serum after consump-
tion of the first or second slice of bread containing either
50 µg or 100 µg each over a period of 1 week even after a
period of pre-saturation. The latter is the amount cur-
rently supplied to the average US citizen in the US fortifi-
cation programme. It is important to remember however
that the level of fortification currently in place in the USA
is based on FDA calculations for delivery of 100 µg of folic
acid at "average intakes". Folic acid in the diet from other
sources other than mandatory folic acid fortified bread
will of course augment these intakes, as breakfast cereals
and many other foodstuffs in the United States are also
fortified with folic acid, for example consumption of a
couple of servings of ready-to-eat breakfast cereals and
toast would easily exceed 200 µg in a single dose. In addi-
tion persons complying with the recommendation to con-
sume a 400 µg supplement daily (estimated to be 30 –
40% of Americans) will have sufficient intakes to lead to
unmetabolised folic acid in serum before they even con-
sume any fortified foods.
Conclusion
Based on the cumulative evidence to date in this and other
studies [4-6] it seems that the threshold dose above which
unmetabolised folic acid appears in serum lies around
200  µg. The intervals between repeated exposures also
seem to be an important factor [6] as an accumulative
effect is observed if repeated doses are consumed close
together. These are important considerations for policy
makers planning an intervention.
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Table 4: Serum folate and folic acid (µg/L). Samples collected on day 7 of regime A bread (50 µg in each slice) pre and post prandially.
pre 50 µg 1 hour post 2 hrs post 3 hrs post 4 hrs post 1 hour post 2nd slice 2 hrs post 3 hrs post
Serum folate i ii iii iv v vi vii viii
Mean 16.91 16.30 16.99 16.88 17.40 15.56 15.40 14.82
SD 6.55 6.62 6.42 6.24 7.12 5.77 6.04 5.21
CI (95%) 13.75 – 20.06 13.11 – 19.49 13.89 – 20.08 13.87 – 19.88 13.97 – 20.83 12.78 – 18.34 12.49 – 18.31 12.31 – 17.33
This table illustrates mean total serum folate (µg/L) concentrations in a group of healthy adult subject (n = 19) exposed to a folic fortified bread for 
1-week. Subject were pre-saturated with folic acid supplements for 14-weeks prior to the bread. The bread was fortified with 50 µg folic acid per 
slice, which was administered twice a day for seven days. The samples shown here were collected on the 7th day of bread consumption pre-
prandially and post-prandially. Standard deviations and confidence intervals are also shown. Serum folic acid was not detectable at any sampling 
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